Rentokil Initial plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc, a foreign private issuer, covers the month of September 2023. The report, dated September 27, 2023, serves as a notification of transactions by persons discharging managerial responsibilities (PDMR) in accordance with Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This document is strictly a regulatory disclosure regarding a specific share transaction and does not contain financial performance data.
Material Changes
The material change disclosed is a share purchase by a Non-Executive Director:
- Person: Sally Johnson (Non-Executive Director)
- Transaction Date: September 26, 2023
- Instrument: Ordinary shares of 1p each (ISIN: GB00B082RF11)
- Volume: 1,964 shares
- Price: 592.2p (£5.922) per share
- Total Value: £11,630.81
- Exchange: London Stock Exchange (XLON)
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of the director's share purchase.
Key Facts for Investor Verification
- Verify the current shareholding balance of Sally Johnson following this purchase.
- Confirm the market price of Rentokil Initial plc shares on September 26, 2023, to contextualize the transaction price.
- Review the company's most recent Form 20-F or interim financial report for actual financial performance metrics, as they are absent in this filing.